Trademark: 90757832
Word
ORI
Status
Registered
Status Code
700
Status Date
Tuesday, July 25, 2023
Serial Number
90757832
Registration Number
7117661
Registration Date
Tuesday, July 25, 2023
Mark Type
4000
Filing Date
Monday, June 7, 2021
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
Oribiotech Limited - Original Registrant

Classifications
9 downloadable computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy, and gene therapy; downloadable computer software platforms for monitoring environmental conditions within buildings, apparatuses and equipment, and for controlling, programming and adjusting devices within a building, facility, grounds, and designated spatial area that control environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for collecting and storing data in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for monitoring patient health, downloadable computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy
42 Software as a service (SaaS) services featuring software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SaaS) services featuring software for monitoring patient health; Software as a service (SaaS) services featuring software for providing information in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for providing information in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy; design and development of scientific equipment and apparatus in the fields of cell culturing, cell therapy and gene therapy; design and development of cell culturing, cell therapy and gene therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; development of cell culturing, cell therapy and gene therapy processes for others; rental and leasing of scientific apparatus and equipment for cell culturing, cell therapy and gene therapy

Trademark Events
Jan 11, 2024
Teas Change Of Correspondence Received
Jan 11, 2024
Teas Change Of Domestic Representatives Address
Jan 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 11, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 11, 2024
Teas Change Of Owner Address Received
Jul 25, 2023
Notice Of Registration Confirmation Emailed
Jul 25, 2023
Registered-Principal Register
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 5, 2023
Approved For Pub - Principal Register
Apr 5, 2023
Examiner's Amendment Entered
Apr 5, 2023
Notification Of Examiners Amendment E-Mailed
Apr 5, 2023
Examiners Amendment E-Mailed
Apr 5, 2023
Examiners Amendment -Written
Mar 15, 2023
Teas/Email Correspondence Entered
Mar 15, 2023
Correspondence Received In Law Office
Mar 14, 2023
Teas Request For Reconsideration Received
Dec 14, 2022
Assignment Of Ownership Not Updated Automatically
Oct 14, 2022
Notification Of Final Refusal Emailed
Oct 14, 2022
Final Refusal E-Mailed
Oct 14, 2022
Final Refusal Written
Sep 20, 2022
Teas/Email Correspondence Entered
Sep 20, 2022
Correspondence Received In Law Office
Sep 19, 2022
Assigned To Lie
Aug 15, 2022
Teas Response To Office Action Received
Feb 14, 2022
Notification Of Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Aug 27, 2021
New Application Office Supplied Data Entered
Jun 10, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24